Beyond oxidative stress, myeloid cells are a crucial source of inflammatory cytokines, which can support the survival and proliferation of neoplastic cells (e.g., IL-6, IL-1, IL-23, IL-17A) or the activation of adaptive anti-tumor immunity (e.g., IL-12, IFNγ). Here, IL6 is linked to neoplasm.